Anti-Cancer Agents in Medicinal Chemistry
Title:Acknowledgements to Reviewers:
Volume: 16 Issue: 12
Export Options
About this article
Cite this article as:
Acknowledgements to Reviewers:, Anti-Cancer Agents in Medicinal Chemistry 2016; 16 (12) . https://dx.doi.org/10.2174/187152061612161104165006
DOI https://dx.doi.org/10.2174/187152061612161104165006 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
22
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Discovery of Small Molecule Fusion Inhibitors Targeting HIV-1 gp41
Current Pharmaceutical Design Bortezomib – First Therapeutic Proteasome Inhibitor for Cancer Therapy: A Review of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review
Current Molecular Medicine 17β-N-arylcarbamoylandrost-4-en-3-one Derivatives as Inhibitors of the Enzymes 3α-Hydroxysteroid Dehydrogenase and 5α-Reductase
Current Enzyme Inhibition Editorial (Thematic Issue: Targeting Telomere Maintenance Mechanisms in Cancer Therapy)
Current Pharmaceutical Design Development, Optimization, Characterization and Impact of In vitro Lipolysis on Drug Release of Telmisartan Loaded SMEDDS
Drug Delivery Letters 3,5-Bis(trifluoromethyl) Phenylammonium triflate(BFPAT) as a Novel Organocatalyst for the Efficient Synthesis of 2,3-dihydroquinazolin-4(1H)-one Derivatives
Current Organic Synthesis MEMS and Microfluidics for Diagnostics Devices
Current Pharmaceutical Biotechnology Radiotracers Based on Technetium-94m
Current Radiopharmaceuticals The ARRONAX Project
Current Radiopharmaceuticals Pharmacotherapy for Smoking Cessation: Present and Future
Current Pharmaceutical Design Editorial [Hot Topic:Imaging and Treatment of Oncological Diseases (Guest Editor: J.F.W. Nijsen)]
Anti-Cancer Agents in Medicinal Chemistry From Target Therapy to miRNA Therapeutics of Human Multiple Myeloma: Theoretical and Technological Issues in the Evolving Scenario
Current Drug Targets Immunophilin Dysfunction and Neuropathology
Current Medicinal Chemistry Role of NF-κB and NF-κB-regulated Gene Products in Chemoresistance and Radioresistance
Current Cancer Therapy Reviews Sample Preparation Techniques for Mass Spectrometry in Proteomics Using Recently Developed Highly Selective Materials
Current Proteomics Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Common Variant in VEGFA and Response to Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration
Current Molecular Medicine Nutrient-By-Genotype Interactions and Personalized Diet: What Can We Learn From Drosophila and Evolutionary Biology?
Current Pharmacogenomics and Personalized Medicine MicroRNAs in Human Virus Genomes: Helping Hands for Viral Infection
MicroRNA